Inventor · disambiguated record
Reinhold Mueller
Also filed as: MUELLER REINHOLD · MUELLER REINHOLD D · MUELLER REINHOLD DIETRICH
22 granted patents·9 pending applications·396 citations·filing 1997–2024
95Inventor score
Top patents by PatentIndex Score
31 records- 0193US6696437B1Heterocyclically substituted benzimidazoles, the production and application thereofABBOTT GMBH & CO KG·Filed 2000·Granted Feb 24, 2004·92 cites·22 claims
- 0292US11312997B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2020·Granted Apr 26, 2022·2 cites·14 claims
- 0392US10738359B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2017·Granted Aug 11, 2020·4 cites·16 claims
- 0492US8283148B2DNA polymerase compositions for quantitative PCR and methods thereofSORGE JOSEPH A·Filed 2003·Granted Oct 9, 2012·66 cites·25 claims
- 0590US9605313B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2013·Granted Mar 28, 2017·6 cites·8 claims
- 0690US8323651B2Antibodies to receptor of advanced glycation end products (RAGE) and uses thereofGU JIJIE·Filed 2009·Granted Dec 4, 2012·29 cites·12 claims
- 0789US7361469B2Dual labeled fluorescent probesSTRATAGENE CALIFORNIA·Filed 2005·Granted Apr 22, 2008·9 cites·55 claims
- 0888US2024401140A1Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2024·Application pending·0 cites
- 0986US6737421B1Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 2000·Granted May 18, 2004·37 cites·23 claims
- 1083US7041675B2Heterocyclic compounds and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 2001·Granted May 9, 2006·22 cites·6 claims
- 1179US10464976B2Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 5, 2019·2 cites·31 claims
- 1279US6063604ATarget nucleic acid sequence amplificationMOLECULAR BIOLOGY RESOURCES·Filed 1997·Granted May 16, 2000·112 cites·32 claims
- 1379US2022356523A1Methods and Processes for Non-Invasive Assessment of Genetic VariationsSEQUENOM INC·Filed 2022·Application pending·0 cites
- 1476US9176150B2Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofHILLEN HEINZ·Filed 2011·Granted Nov 3, 2015·3 cites·12 claims
- 1575US7491729B23-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereofABBOTT GMBH & CO KG·Filed 2003·Granted Feb 17, 2009·9 cites·18 claims
- 1669US9394363B2Antibodies to receptor of advanced glycation end products (RAGE) and uses thereofABBVIE DEUTSCHLAND·Filed 2012·Granted Jul 19, 2016·1 cites·10 claims
- 1765US7906120B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)ABBOTT LAB·Filed 2007·Granted Mar 15, 2011·0 cites·21 claims
- 1864US2010209346A1Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofHILLEN HEINZ·Filed 2009·Application pending·0 cites
- 1963US9255146B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 9, 2016·0 cites·6 claims
- 2063US8906864B2Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their useMULLER BERNHARD K·Filed 2006·Granted Dec 9, 2014·2 cites·6 claims
- 2163US2019233510A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2261US10040852B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Granted Aug 7, 2018·0 cites·14 claims
- 2354US2011142845A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBOTT LAB·Filed 2010·Application pending·0 cites
- 2450US2005048517A1Compositions and methods for polynucleotide detectionSTRATAGENE INC·Filed 2003·Application pending·0 cites
- 2548US11172793B2Paper roll dampenerMUELLER REINHOLD·Filed 2019·Granted Nov 16, 2021·0 cites·19 claims
- 2648US2017002075A1Antibodies to receptor of advanced glycation end products (rage) and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 2748US2005250112A1Nucleic acids, compositions, methods, and kits for detecting mycoplasma and acholeplasma speciesPADMABANDU GOTHAMI A·Filed 2004·Application pending·0 cites
- 2841US10766457B2Vehicle inhibitor with override system and methodMUELLER REINHOLD·Filed 2018·Granted Sep 8, 2020·0 cites·19 claims
- 2941US7026311B2Dibenzodiazepine derivatives, their preparation and useABBOTT GMBH & CO KG·Filed 2002·Granted Apr 11, 2006·0 cites·11 claims
- 3033US11142164B2Vehicle inhibitorMUELLER REINHOLD·Filed 2020·Granted Oct 12, 2021·0 cites·19 claims
- 3129US2016002343A1Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseasesABBVIE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Reinhold Mueller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →